CD5 and myeloid sarcoma: Second, several CD5, CD6, and/or CD166/ALCAM gene variants have been associated with different IMIDs, such as RA (38), lupus nephritis (39), MS (40–42), psoriasis (43), Behçet's disease (44), and IBD (45, 46) (Supplementary Table 2).